-
Signature
-
/s/ Marshall Stanton
-
Issuer symbol
-
AORT
-
Transactions as of
-
13 Jun 2025
-
Net transactions value
-
-$743,131
-
Form type
-
4
-
Filing time
-
16 Jun 2025, 20:22:21 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Stanton Marshall S. |
SVP, Clinical & MD Affair |
1655 ROBERTS BLVD., NW, KENNESAW |
/s/ Marshall Stanton |
16 Jun 2025 |
0001849615 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AORT |
Common Stock |
Sale |
$248,953 |
-8,747 |
-8.3% |
$28.46 |
96,585 |
13 Jun 2025 |
Direct |
F1, F2 |
| transaction |
AORT |
Common Stock |
Sale |
$35,669 |
-1,253 |
-1.3% |
$28.47 |
95,332 |
13 Jun 2025 |
Direct |
F1, F3 |
| transaction |
AORT |
Common Stock |
Sale |
$406,601 |
-14,306 |
-15% |
$28.42 |
81,026 |
13 Jun 2025 |
Direct |
F1, F4 |
| transaction |
AORT |
Common Stock |
Sale |
$51,909 |
-1,826 |
-2.3% |
$28.43 |
79,200 |
13 Jun 2025 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: